Comparative study of sitagliptin, vildagliptin and alogliptin in patients with type 2 diabetes inadequately controlled with metformin and/or sulfonylurea: a randomized, open labeled trial.

Trial Profile

Comparative study of sitagliptin, vildagliptin and alogliptin in patients with type 2 diabetes inadequately controlled with metformin and/or sulfonylurea: a randomized, open labeled trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 May 2016

At a glance

  • Drugs Alogliptin (Primary) ; Sitagliptin (Primary) ; Vildagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Nov 2012 Planned number of patients changed from 200 to 300 as reported by University Hospital Medical Information Network - Japan.
    • 12 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 12 Nov 2012 Planned End Date changed from 31 Dec 2014 to 1 Dec 2014 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top